Arvelle Therapeutics

Arvelle Therapeutics
Arvelle Therapeutics
Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders.
Basel
Biotechnology, innovation
Above €25 million
2019
www.arvelletx.com/
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Arvelle Therapeutics? We’re happy to assist you with our Startup Sourcing service.